Viewing SEC Facts Units
Company Name:
Summit Therapeutics Inc.
CIK:
1599298
Start Filing Date:
2020-04-01
End Filing Date:
2020-06-30
ACCN:
0001599298-20-000039
Value:
$ 67,232,000
Value Error:
$ None
Created By:
Date Filed:
2020-09-29
FY:
2020
Fiscal Period:
Q2
Frame:
CY2019Q2
Type:
us-gaap
Form:
8-K
Units:
shares